epithelial-mesenchymal transition: new insights in signaling, development, and disease

The conversion of an epithelial cell to a mesenchymal cell is critical to metazoan embryogenesis and a defining structural feature of organ development. Current interest in this process, which is described as an epithelial-mesenchymal transition (EMT), stems from its developmental importance and its...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of cell biology Vol. 172; no. 7; pp. 973 - 981
Main Authors Lee, Jonathan M, Dedhar, Shoukat, Kalluri, Raghu, Thompson, Erik W
Format Journal Article
LanguageEnglish
Published United States The Rockefeller University Press 27.03.2006
Rockefeller University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The conversion of an epithelial cell to a mesenchymal cell is critical to metazoan embryogenesis and a defining structural feature of organ development. Current interest in this process, which is described as an epithelial-mesenchymal transition (EMT), stems from its developmental importance and its involvement in several adult pathologies. Interest and research in EMT are currently at a high level, as seen by the attendance at the recent EMT meeting in Vancouver, Canada (October 1-3, 2005). The meeting, which was hosted by The EMT International Association, was the second international EMT meeting, the first being held in Port Douglas, Queensland, Australia in October 2003. The EMT International Association was formed in 2002 to provide an international body for those interested in EMT and the reverse process, mesenchymal-epithelial transition, and, most importantly, to bring together those working on EMT in development, cancer, fibrosis, and pathology. These themes continued during the recent meeting in Vancouver. Discussion at the Vancouver meeting spanned several areas of research, including signaling pathway activation of EMT and the transcription factors and gene targets involved. Also covered in detail was the basic cell biology of EMT and its role in cancer and fibrosis, as well as the identification of new markers to facilitate the observation of EMT in vivo. This is particularly important because the potential contribution of EMT during neoplasia is the subject of vigorous scientific debate (Tarin, D., E.W. Thompson, and D.F. Newgreen. 2005. Cancer Res. 65:5996-6000; Thompson, E.W., D.F. Newgreen, and D. Tarin. 2005. Cancer Res. 65:5991-5995).
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Review-3
Abbreviations used in this paper: BMP7, bone-morphogenic protein 7; EGFR, EGF receptor; EMT, epithelial–mesenchymal transition; ER, estrogen receptor; FSP1, fibroblast-specific protein 1; GSK, glycogen synthase kinase; ILK, integrin-linked kinase; MET, mesenchymal–epithelial transition; MMP, matrix metalloproteinase; OSE, ovarian surface epithelium; PARP-1, poly-ADP-ribose polymerase 1; ROS, reactive oxygen species; siRNA, small interfering RNA.
Correspondence to Shoukat Dedhar: sdedhar@interchange.ubc.ca
ISSN:0021-9525
1540-8140
DOI:10.1083/jcb.200601018